课题基金 / 基金详情

Roles of Voltage- and cation-independent TRPC channels in cardiac hypertrophy

Roles of Voltage- and cation-independent TRPC channels in cardiac hypertrophy
电压和阳离子无关的 TRPC 通道在心脏肥大中的作用
批准号:
20390025
负责人:
KUROSE Hitoshi
金额:
$12.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

KUROSE Hitoshi的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have reported that angiotensin II or endothelin-1 stimulation induce hypertrophic responses through transient receptor potential canonical channel 3 (TRPC3) and TRPC6-mediated Ca2+ influx using rat neonatal cardiomyocytes. TRPC3/TRPC6 are voltage-independent and cation-non-selective ion channels, and activated by diacylglycerol generated by Gq-stimulated phospholipase C activation. However, these results were obtained from in vitro cell system using receptor stimulation of cardiomyocytes isolated from newborn rats. It is essential to demonstrate the importance of TRPC3/TRPC6 in in vivo hypertrophy model. Therefore, we have examined whether TRPC3/TRPC6 are involved in pressure overload-induced cardiac hypertrophy. Pressure overload is considered as a mouse model of chronic human hypertension, and induces cardiac hypertrophy. As the compound Pyr3 that selectively inhibits TRPC3 was available, we obtained it and administered to pressure overloaded mice. Pressure overload is applied by … More transverse aortic constriction procedure (TAC), and Pyr3 is administered by osmotic mini-pump. Pressure overload-induced hypertrophy was inhibited in Pyr3-treated mice as compare to wild type mice, which was as assessed by increased size of cardiomyocytes and increased expression of ANP. Furthermore, cardiac function such as fractional shortening is improved by the treatment with Pyr3. Next, we also examined the involvement of TRPC6 in pressure overload-induced cardiac hypertrophy. As the function of TRPC6 is inhibited by phosphorylation of TRPC6, we used a cGMP-selective phosphodiesterase (phosphodiesterase type 5:PDE5) inhibitor, sildenafil, for the increase in cardiac cGMP content. The treatment with sildenafil inhibited cardiac hypertrophy by pressure overload. The increased expression of various marker genes of hypertrophy was inhibited by the treatment with sildenafil. In sidenafil-treated mice, anti-phospho-TRPC6 antibody revealed that TRPC6 was phosphorylated at a specific site that is essential for TRPC6-mediated Ca^<2+> influx. These results suggest that TRPC3/TRPC6-mediated Ca^<2+> influx plays an important role in cardiac hypertrophy in vivo as well as in vitro. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
心臓の線維化
心脏纤维化
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Yamazaki, J., Katoh, H., Yamguchi, Y., Negishi, M., 黒瀬等]
通讯作者: 黒瀬等
βアドレナリン受容体遮断薬によるGRK5/βアレスチン2を介した心臓の線維化
GRK5/β-arrestin 2介导的β-肾上腺素受体阻滞剂诱导的心脏纤维化
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [仲矢道雄, 西田基宏, 黒瀬等]
通讯作者: 黒瀬等
DOI: 10.1016/j.cellsig.2008.02.016
发表时间: 2008-07-01
期刊: CELLULAR SIGNALLING
影响因子: 4.8
作者: [Obara, Yutaro, Okano, Yumiko, Nakahata, Norimichi]
通讯作者: Nakahata, Norimichi
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Role of GRK in engulfment of apoptotic cells
    • 批准号:
      23659043
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KUROSE Hitoshi
    • 依托单位:
    The mechanism of G protein-mediated cardiac fibrosis
    • 批准号:
      18390028
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.99万
    • 财政年份:
      2006
    • 负责人:
      KUROSE Hitoshi
    • 依托单位:
    mechanistic analysis of cardiac functions by building G protein signal network
    • 批准号:
      17079007
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $47.49万
    • 财政年份:
      2005
    • 负责人:
      KUROSE Hitoshi
    • 依托单位:
    Establishment of a role of reactive oxygen species as a second messenger
    • 批准号:
      15390027
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.92万
    • 财政年份:
      2003
    • 负责人:
      KUROSE Hitoshi
    • 依托单位: